| EPA0061 | Young adults with perinatally-acquired HIV from Argentina present differential IPDA-determined HIV reservoir composition and immune phenotype: distinctive strategies needed for HIV cure? | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0062 | Viral rebound dynamics in SHIV-infected infant macaques are predicted by distinct immunovirologic features measured before and after one year of antiretroviral therapy | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0063 | Meta-analysis of 5’-Leader defective proviruses persisting in people on ART | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0064 | Adaptation of the intact proviral DNA assay to the QIAcuity digital PCR platform | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0065 | The frontal lobe is a major reservoir of intact HIV proviral DNA in the brain despite viral suppression with ART | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0066 | CTL epitopes from structurally important HIV proteins are identified in rebound HIV | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0067 | The cellular factor UHRF1 silences HIV-1 transcription in infected myeloid reservoirs | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0068 | Long-term protection against HIV infection after discontinuation treatment with ponatinib for 1 year | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0069 | A case of persistent low-level viremia during ART fueled by a clonally expanded provirus with a 3 base deletion in HIV's major splice donor site | E-poster | Understanding and targeting persistent HIV reservoirs |
| EPA0070 | Myeloid production of GDF15 influences HIV reservoir size in ART-treated people living with HIV | E-poster | Understanding and targeting persistent HIV reservoirs |